Your session is about to expire
← Back to Search
Peptide Dimer
KSP/QRH dimer for Barrett's Esophagus
Phase 1
Waitlist Available
Led By Danielle K Turgeon, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Has known or suspected Barrett's esophagus
Willing and able to sign informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during and immediately after procedure, generally no more than 2 hours
Awards & highlights
Study Summary
This trial is looking at using a new imaging agent, a fluorescent-labeled peptide dimer, to help guide endoscopic biopsy or endoscopic mucosal resection (EMR) for patients with Barrett's esophagus.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during and immediately after procedure, generally no more than 2 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during and immediately after procedure, generally no more than 2 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Binding of KSP/QRH dimer to EGFR and HER2
SFE ability to detect dimer by SNR
SFE ability to detect dimer by fluorescence T/B ratio
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Esophagus sprayed with KSP/QRH dimerExperimental Treatment1 Intervention
Area of interest in subject's esophagus sprayed with KSP/QRH dimer and imaged with the SFE probe
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,785 Previous Clinical Trials
6,364,792 Total Patients Enrolled
Danielle K Turgeon, MDPrincipal InvestigatorUniversity of Michigan
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger